The global hospital infection therapeutics market is poised for steady growth through 2031, driven by the increasing prevalence of healthcare-associated infections (HAIs), growing antimicrobial resistance concerns, and rising investments in advanced infection management solutions. According to recent industry analysis, the global hospital infection therapeutics industry was valued at US$ 11.3...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek